EcoDrugPlus

Retinoic Acid Receptor Rxr-Beta-B

Ensembl ID : ENSAMXG00000043713
Gene Symbol: LOC103040717
3 Cross references
215 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSAMXG00000010737
Gene Symbol: RARB
2 Cross references
394 Possible Orthologues:

Retinoic Acid Receptor Gamma-A

Ensembl ID : ENSAMXG00000029553
Gene Symbol: LOC103046242
3 Cross references
326 Possible Orthologues:

Rho-Associated Protein Kinase 2

Ensembl ID : ENSAMXG00000021207
Gene Symbol: LOC103042784
3 Cross references
216 Possible Orthologues:

Rho-Associated, Coiled-Coil Containing Protein Kinase 2b

Ensembl ID : ENSAMXG00000003869
Gene Symbol: ROCK2B
1 Cross references
214 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSAMXG00000032692
Gene Symbol: RPL10A
3 Cross references
381 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSAMXG00000034710
Gene Symbol: RPL11
3 Cross references
288 Possible Orthologues:

Ribosomal Protein L12

Ensembl ID : ENSAMXG00000012766
Gene Symbol: RPL12
3 Cross references
490 Possible Orthologues:

Ribosomal Protein L13

Ensembl ID : ENSAMXG00000006495
Gene Symbol: RPL13
3 Cross references
272 Possible Orthologues:

Ribosomal Protein L13a

Ensembl ID : ENSAMXG00000033532
Gene Symbol: RPL13A
3 Cross references
370 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSAMXG00000036907
Gene Symbol: RPL14
3 Cross references
311 Possible Orthologues:

Ribosomal Protein L15

Ensembl ID : ENSAMXG00000037435
Gene Symbol: RPL15
3 Cross references
376 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).